Invention Grant
- Patent Title: Dual selective P13 delta and gamma kinase inhibitors
-
Application No.: US15672061Application Date: 2017-08-08
-
Publication No.: US10851107B2Publication Date: 2020-12-01
- Inventor: Swaroop K. Vakkalanka , Prashant K. Bhavar , Srikant Viswanadha , Govindarajulu Babu
- Applicant: Rhizen Pharmaceuticals SA
- Applicant Address: CH La Chaux-de-Fonds
- Assignee: RHIZEN PHARMACEUTICALS SA
- Current Assignee: RHIZEN PHARMACEUTICALS SA
- Current Assignee Address: CH La Chaux-de-Fonds
- Agency: Blank Rome LLP
- Priority: IN2501/CHE/2013 20130607; IN5567/CHE/2013 20131203
- Main IPC: A61K31/52
- IPC: A61K31/52 ; C07D473/34 ; C07D473/04 ; A61K45/06
Abstract:
The present invention relates to dual delta (δ) and gamma (γ) PI3K protein kinase modulators, methods of preparing them, pharmaceutical compositions containing them and methods of treatment, prevention and/or amelioration of Pi3K kinase mediated diseases or disorders with them.
Public/Granted literature
- US20170334914A1 DUAL SELECTIVE PI3 DELTA AND GAMMA KINASE INHIBITORS Public/Granted day:2017-11-23
Information query
IPC分类:
